Boston Scientific Corp. vs. Beyond Air, Inc. Common Stock
Boston Scientific Corp. (BSX) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| BSX | XAIR | |
|---|---|---|
| Market Cap | $63.53 billion | $3.04 million |
| Revenue (TTM) | — | $7.69 million |
| Net Income (TTM) | — | $-34,410,000 |
BSX leads on 1 of 1 size & scale factors.
Valuation
| BSX | XAIR | |
|---|---|---|
| Price / Book | — | 1.07 |
| Price / Sales | — | 0.40 |
BSX and XAIR split the valuation factors evenly.
Profitability
| BSX | XAIR | |
|---|---|---|
| Net Margin | — | -447.64% |
| Return on Equity | — | -1212.05% |
BSX and XAIR split the profitability factors evenly.
Risk & Sentiment
| BSX | XAIR | |
|---|---|---|
| Short Interest | 0.72% | 5.73% |
BSX leads on 1 of 1 risk & sentiment factors.
Dig deeper: BSX overview, BSX financials, XAIR overview, XAIR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.